Kymora B. Scotland

Dr. Kymora B. Scotland

Department of Urology, University of California, Los Angeles, CA, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Endourology
Verified
Journal Article
Closed access
KSKaren L. Stern
Karen L. Stern
NCNoah Canvasser
Noah Canvasser
MBMichael Borofsky
Michael Borofsky
VGVanessa M. Gleason
Vanessa M. Gleason
GKGuido Kamphuis
Guido Kamphuis
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
Introduction Kidney stones affect 1 in every 11 people in the United States each year. There is a significant high recurrence rate without a stone prevention protocol. Alkali citrate is beneficial in decreasing stone recurrence, but due to the cost and gastrointestinal side effects there is a low adherence rate. This study aims to serve as a review of some of the most commonly used alkalizing over- the- counter supplements that are advertised to prevent and treat kidney stones. Methods Data was gathered by a comprehensive online literature search and company inquiries for kidney stone prevention supplements. An additional informal poll of the authors selected supplements that are most commonly taken by their patients. A total of eight supplements were evaluated for cost, alkali equivalent provided, dosing and regulatory information. Results Eight of the most commonly used supplements were reviewed with a focus on alkalizing agents. Information reviewed revealed dosing recommendations resulting in decreased citrate alkali equivalents per day compared to prescription-strength potassium citrate. Cost, peer-reviewed study results and regulatory data were reviewed, tabulated and analyzed. Cost per alkali equivalent was substantially decreased for each supplement compared to the prescribed drug. All supplements were found to be readily available online. Conclusion Over- the- counter alkalizing agents are available to patients and may be an appropriate alternative to cost prohibitive potassium citrate when treating urolithiasis patients. Additional testing will be necessary in the future to determine the efficacy of these supplements in the treatment and prevention of urinary stone disease.

1 July 2022 in Journal of Endourology
Verified
Journal Article
Closed access
PDParris Diaz
Parris Diaz
RTRebecca A. Takele
Rebecca A. Takele
STSapna Thaker
Sapna Thaker
KTKaraan N. Thaker
Karaan N. Thaker
JBJorge Ballon
Jorge Ballon
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
An increasing number of patients are utilizing the internet to answer their medical questions. Given the lack of verified stone treatment resources on the web, we sought to evaluate online interest in kidney stone surgical interventions and assess the quality of the most popular resources on social media. Google Trends was used to evaluate public interest in different kidney stone interventions between March 2016 and February 2021 and reported as search volume index (SVI). Next, the social media analysis tool, BuzzSumo, was used to identify stone surgery content online on the social media platforms, YouTube, Instagram, Pinterest, Reddit, and Twitter. To evaluate the quality of health information presented in the online resources, the DISCERN instrument was employed by three individual raters. Ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), and extracorporeal shockwave lithotripsy (SWL) were identified as the top search terms on Google Trends with mean SVIs of 47.75, 42.98, and 45.74, respectively ( p = 0.012). On YouTube, URS, PCNL, and SWL had 12,549, 116,222, and 20,717 views, respectively. Nine articles and fifteen videos were chosen for analysis using the DISCERN tool with a mean score of 2.82 and 2.27, respectively, among three independent evaluators. The result of our study suggests that online users are interested in URS but engaged more often with PCNL content on social media platforms. We found that the quality of online resources related to stone surgery highlights the need for involvement of urologists in creation of engaging high-quality content and sharing of accurate information in a social media-driven society.

1 January 2021 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JCJustin Y.H. Chan
Justin Y.H. Chan
VWVictor Wong
Victor Wong
JWJulie Wong
Julie Wong
RPRyan F. Paterson
Ryan F. Paterson
Dirk LangeDirk Lange
Dirk Lange
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
Chan JY, et al. Investig Clin Urol. 2020 Aug;62:e24. https://doi.org/10.4111/icu.20200319

Verified
Journal Article
Open access
PDF file
SSSimone Stoots
Simone Stoots
GKGuido M. Kamphuis
Guido M. Kamphuis
RGRobert Geraghty
Robert Geraghty
LVLiffert Vogt
Liffert Vogt
MHMichaël Henderickx
Michaël Henderickx
BSBhaskar K Somani
Bhaskar K Somani
Kidney stone disease (KSD) is a complex disease. Besides the high risk of recurrence, its association with systemic disorders contributes to the burden of disease. Sufficient water intake is crucial for prevention of KSD, however, the mineral content of water might influence stone formation, bone health and cardiovascular (CVD) risk. This study aims to analyse the variations in mineral content of bottled drinking water worldwide to evaluate the differences and describes the possible impact on nephrological and urological diseases. The information regarding mineral composition (mg/L) on calcium, bicarbonate, magnesium, sodium and sulphates was read from the ingredients label on water bottles by visiting the supermarket or consulting the online shop. The bottled waters in two main supermarkets in 21 countries were included. The evaluation shows that on a global level the mineral composition of bottled drinkable water varies enormously. Median bicarbonate levels varied by factors of 12.6 and 57.3 for still and sparkling water, respectively. Median calcium levels varied by factors of 18.7 and 7.4 for still and sparkling water, respectively. As the mineral content of bottled drinking water varies enormously worldwide and mineral intake through water might influence stone formation, bone health and CVD risk, urologists and nephrologists should counsel their patients on an individual level regarding water intake.

1 May 2020 in Journal of Chromatography B
Verified
Journal Article
Closed access
ZHZi-Ao Huang
Zi-Ao Huang
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
YLYueyang Li
Yueyang Li
JTJiahua Tan
Jiahua Tan
SKSonia H.Y. Kung
Sonia H.Y. Kung
Dirk LangeDirk Lange
Dirk Lange

8 April 2015 in BMC Urology
Verified
Journal Article
Open access
PDF file
RTRyuta Tanimoto
Ryuta Tanimoto
YFYomi Fashola
Yomi Fashola
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
ACAnne E Calvaresi
Anne E Calvaresi
LGLeonard G Gomella
Leonard G Gomella
CLCostas D. Lallas
Costas D. Lallas
Radical prostatectomy is a standard surgical treatment of clinically localized prostate cancer. Margin status has been found to be an independent predictor of biochemical recurrence (BCR) after open radical prostatectomy in several large series but this is still controversy in Robotic Assisted Radical Prostatectomy (RARP) series. We therefore wanted to investigate the prognostic significance of positive surgical margin (PSM) and other pathological factors on BCR in patients treated with RARP by a single surgeon. Prospectively collected data of 439 patients treated with RARP between October 2005 and June 2013 by a single surgeon at a single institution were analyzed. BCR was defined as follow-up PSA level > 0.2 ng/ml on two separate occasions or patients who had to undergo salvage therapy. Kaplan Meier curves and Log Rank test were used to compare the risk of BCR. Univariate and Multivariate Cox Regression analyses were performed to determine the prognostic impact of age, BMI, prostate weight, PSA prior to surgery, pathological T-stage, pathological Gleason sum, PSM and operative period. In this study period, 34 out of 439 had BCR, giving an overall BCR rate of 7.7% for this cohort. Overall 2- and 3-year BCR-free survival rates were 93% and 88%, respectively. Patients with a PSM had a 2-year BCR free survival of 88% compared to 94% in those with negative margins (p < .0001). On the multivariate analysis, PSM as well as pathological Gleason sum > = 8, PSA, pathological stage and operative period were significantly associated with BCR. In our case series of RARP performed by a single surgeon, PSM as well as pathological Gleason sum, PSA, pathological stage and early operative period for this surgeon were the independent predictors of BCR.